NYSE - Delayed Quote • USD
Elevance Health, Inc. (ELV)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 17 | 17 |
| Avg. Estimate | 10.01 | 9.83 | 37.28 | 41.62 |
| Low Estimate | 9.82 | 9.21 | 37.2 | 40.11 |
| High Estimate | 10.28 | 10.51 | 37.38 | 42.3 |
| Year Ago EPS | 9.04 | 8.99 | 33.14 | 37.28 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 14 |
| Avg. Estimate | 43B | 42.98B | 171.97B | 183.15B |
| Low Estimate | 42.4B | 42.45B | 170.44B | 178.56B |
| High Estimate | 43.53B | 43.62B | 173.93B | 187.68B |
| Year Ago Sales | -- | 42.62B | 170.21B | 171.97B |
| Sales Growth (year/est) | -- | 0.90% | 1.00% | 6.50% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 8.8 | 8.44 | 5.64 | 10.53 |
| EPS Actual | 9.04 | 8.99 | 5.62 | 10.64 |
| Difference | 0.24 | 0.55 | -0.02 | 0.11 |
| Surprise % | 2.70% | 6.50% | -0.40% | 1.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 10.01 | 9.83 | 37.28 | 41.62 |
| 7 Days Ago | 10.12 | 9.84 | 37.18 | 41.61 |
| 30 Days Ago | 10.15 | 9.84 | 37.13 | 41.55 |
| 60 Days Ago | 10.15 | 9.83 | 37.15 | 41.56 |
| 90 Days Ago | 10.11 | 9.77 | 37.14 | 41.51 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 3 | 9 | 7 |
| Up Last 30 Days | 3 | 7 | 18 | 14 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 5 | 4 | -- | -- |
Growth Estimates
| CURRENCY IN USD | ELV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 10.70% | -- | -- | 6.50% |
| Next Qtr. | 9.30% | -- | -- | 12.00% |
| Current Year | 12.50% | -- | -- | 5.30% |
| Next Year | 11.60% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 12.10% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 12.97% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Mizuho: Buy to Buy | 4/24/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 4/19/2024 |
| Maintains | UBS: Buy to Buy | 4/19/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/19/2024 |
| Reiterates | Truist Securities: Buy to Buy | 4/19/2024 |
| Maintains | Jefferies: Buy to Buy | 4/19/2024 |
Related Tickers
CI The Cigna Group
354.47
-0.01%
CNC Centene Corporation
74.00
-2.22%
MOH Molina Healthcare, Inc.
342.23
-2.86%
HUM Humana Inc.
305.90
-1.77%
UNH UnitedHealth Group Incorporated
495.35
+0.30%
CVS CVS Health Corporation
67.18
-0.22%
OSCR Oscar Health, Inc.
17.56
-1.84%
ALHC Alignment Healthcare, Inc.
5.21
+0.97%
NEUE NeueHealth, Inc.
6.11
-3.54%
CLOV Clover Health Investments, Corp.
0.6800
+1.49%